Happy Holidays! Over 120,000 eBooks at just 19.99 each— Pick a favorite today

Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders

Editors: Rybakowski, Janusz K., Serretti, Alessandro (Eds.)

  • Updated comprehensive review of the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression
    Modern pharmacogenomics of the most important psychotropic drugs such as antipsychotics, antidepressants and mood stabilizers 
    The attempts to use pharmacogenetics of antipsychotics, antidepressant and mood-stabilizing drugs in practice
    Perspectives for future research in pharmacogenetics in major psychoses

Buy this book

eBook 51,16 €
price for Spain (gross)
  • ISBN 978-3-319-27040-1
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover 62,39 €
price for Spain (gross)
  • ISBN 978-3-319-27038-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
  • The final prices may differ from the prices shown due to specifics of VAT rules
About this book

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.

Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. 

About the authors

Prof. Janusz K. Rybakowski has been the Head of Department of Adult Psychiatry, Poznan University of Medical Sciences, Poland, since 1994. He has authored over 500 scientific articles and book chapters on clinical psychiatry, neurobiology and psychopharmacology and his present Hirsch Index is 40. He is the author of the book “The Faces of Manic-Depressive Illness” (2009) and a member of many scientific societies including ECNP, CINP, Society of Biological Psychiatry, International Society of Psychiatric Genetics, International Society of Affective Disorders and International Society of Bipolar Disorders. He serves on editorial boards of numerous international journals and is the Field Editor of the World Journal of Biological Psychiatry. From 1998-2001 he was the President of the Polish Psychiatric Association. In 2012, he received the Lifetime Achievement Award of the European Bipolar Forum and in 2015, the Lifetime Achievement Award in Biological Psychiatry.

Reviews

“The editors are successful in filling a gap in the literature of research findings about pharmacogenetics as related to psychiatry, as no major book has been published in this area since 2011. Because this is a growing field with great potential, an update is necessary. … psychiatrists or pharmacologists involved in research would get the most from this book. … Each chapter begins with an abstract, has various charts and tables, and concludes with references.” (Aaron Plattner, Doody's Book Reviews, June, 2016)

“The book provides a reader with the full insight into present knowledge of genetic influences on response to drug treatment for major psychiatric disorders such as schizophrenia, bipolar disorder and depression. It helps the reader with better understanding how genetic factors influence psychotropic drug response. … book highlights the benefits of pharmaco-genetics in means of reduced suffering and social economic benefits and it also outlines some new directions for future research. This work contributes significantly to the field of psychiatry.” (Vivian Badžim, Alcoholism and Psychiatry Research, Vol. 52, 2016)


Table of contents (7 chapters)

  • Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia

    Arranz, María J. (et al.)

    Pages 1-20

    Preview Buy Chapter 30,19 €
  • Pharmacogenetics of Serious Antipsychotic Side Effects

    Maciukiewicz, Malgorzata (et al.)

    Pages 21-38

    Preview Buy Chapter 30,19 €
  • Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs

    Fabbri, Chiara (et al.)

    Pages 39-54

    Preview Buy Chapter 30,19 €
  • Genomic Studies of Treatment Resistance in Major Depressive Disorder

    Perlis, Roy H.

    Pages 55-65

    Preview Buy Chapter 30,19 €
  • Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression

    Menke, Andreas (et al.)

    Pages 67-92

    Preview Buy Chapter 30,19 €

Buy this book

eBook 51,16 €
price for Spain (gross)
  • ISBN 978-3-319-27040-1
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover 62,39 €
price for Spain (gross)
  • ISBN 978-3-319-27038-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
  • The final prices may differ from the prices shown due to specifics of VAT rules
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
Editors
  • Janusz K. Rybakowski
  • Alessandro Serretti
Copyright
2016
Publisher
ADIS
Copyright Holder
Springer International Publishing Switzerland
eBook ISBN
978-3-319-27040-1
DOI
10.1007/978-3-319-27040-1
Hardcover ISBN
978-3-319-27038-8
Edition Number
1
Number of Pages
IX, 117
Topics